Physician profile
Kyle Chepla
NPI 1073792255
$163,283.75
in general payments reported to CMS, 2019-2025
11 companies · $89K in 2025
The $89K reported for 2025 was more than what 99% of Surgery of The Hand (Plastic Surgery) providers received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $411 · 2020: $4,492 · 2021: $292 · 2022: $788 · 2023: $4,028 · 2024: $65K · 2025: $89K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $112K · Travel and Lodging: $21K · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $20K · Food and Beverage: $4,811.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $111,599.00 |
| Travel and Lodging | $20,607.11 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $20,284.04 |
| Food and Beverage | $4,811.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Polynovo North America LLC | $132,969.24 | 2019-2025 | Novosorb Btm |
| Checkpoint Surgical, INC | $29,416.45 | 2019-2025 | Checkpoint Stimulators |
| Acumed LLC | $179.73 | 2020-2023 | Acumed, Inframe Implant |
| Integra Lifesciences Corporation | $155.57 | 2019 | |
| Baxter Healthcare | $144.70 | 2025 | Artiss |
| Abbvie INC. | $142.02 | 2023 | Botox |
| Trimed, INC. | $126.06 | 2025 | |
| Smith+Nephew, INC. | $89.24 | 2024 | Evos |
| Acera Surgical, INC. | $25.74 | 2025 | Restrata Wound Matrix |
| Stryker Corporation | $19.94 | 2025 | Variax |
| Arthrosurface Incorporated | $15.06 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Chepla listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.